Short answer
Nurix Therapeutics, Inc. (NRIX) filed an 8-K current report with the SEC on July 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal quarter ended May 31, 2026 financial results announced by Nurix Therapeutics.
Nurix Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended May 31, 2026 financial results announced by Nurix Therapeutics
- Press release furnished as Exhibit 99.1 contains the results and investor-relevant financial details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nurix Therapeutics, Inc. 8-K filings
Get the next NRIX 8-K as it lands
Follow NRIX for push alerts, or ask the research agent what this filing means.